Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (2) , 171-174
- https://doi.org/10.1016/0959-8049(94)90081-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- RasOncogene Mutations in Benign and Malignant Thyroid NeoplasmsJournal of Clinical Endocrinology & Metabolism, 1991
- Medullary Thyroid Cancer: An Immunohistochemical and Humoral Study Using Six Separate AntigensAmerican Journal of Clinical Pathology, 1991
- Expression ofras p21 Protein by ThymomaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1990
- Papillary Thyroid CarcinomaEndocrinology and Metabolism Clinics of North America, 1990
- H-Ras Protooncogene Mutations in Human Thyroid Neoplasms*Journal of Clinical Endocrinology & Metabolism, 1990
- Application of automated image analysis to demonstrate the correlation between ras p21 expression and severity of gliomasBiochemical and Biophysical Research Communications, 1990
- Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissuesCancer, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Oncogene expression in human tumorsInternational Journal of Cancer, 1985
- Thyroid carcinoma: Pathologic classification with data on prognosisSeminars in Nuclear Medicine, 1971